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Background The clinical presentation of influenza in infancy
may be similar to serious bacterial infection and be investigated
with invasive procedures like lumbar puncture (LP), despite very
limited evidence that influenza occurs concomitantly with
bacterial meningitis, perhaps because the diagnosis of influenza is
very often not established when the decision to perform LP is
being considered.
Methods A retrospective medical record review was undertaken
in all children presenting to the Children’s Hospital at Westmead,
Sydney, Australia, in one winter season with laboratory-confirmed
influenza or other respiratory virus infections (ORVIs) but
excluding respiratory syncytial virus, to compare the use of, and
reflect on the need for, the performance of invasive diagnostic
procedures, principally LP, but also blood culture, in influenza
and non-influenza cases. We also determined the rate of
concomitant bacterial meningitis or bacteraemia.
Findings Of 294 children, 51% had laboratory-confirmed
influenza and 49% had ORVIs such as parainfluenza viruses
(34%) and adenoviruses (15%). Of those with influenza, 18% had
a LP and 71% had a blood culture performed compared with
6Æ3% and 55Æ5% in the ORVI group (for both P < 0Æ01). In
multivariate analysis, diagnosis of influenza was a strong
independent predictor of both LP (P = 0Æ02) and blood culture
(P = 0Æ05) being performed, and, in comparison with ORVIs,
influenza cases were almost three times more likely to have a LP
performed on presentation to hospital. One child with influenza
(0Æ9%) had bacteraemia and none had meningitis.
Interpretation Children with influenza were more likely to
undergo LP on presentation to hospital compared with those
presenting with ORVIs. If influenza is confirmed on admission by
near-patient testing, clinicians may be reassured and less inclined
to perform LP, although if meningitis is clinically suspected, the
clinician should act accordingly. We found that the risk of
bacterial meningitis and bacteraemia was very low in hospitalised
children with influenza and ORVIs. A systematic review should be
performed to investigate this across a large number of settings.
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Introduction
Influenza in children poses a significant burden to health-
care services and often requires escalated medical care.1,2 A
large proportion of the children with influenza admitted to
hospital receive antibiotics for suspected bacterial infection
and undergo multiple invasive procedures. For instance,
during the winter of 2006, among children aged <5 years
admitted to the Children’s Hospital at Westmead (CHW)
with laboratory-confirmed influenza, 68% received intrave-
nous antibiotics and 23% underwent lumbar puncture
(LP).3 The following year, 2007, similar proportions of
hospitalised children with confirmed influenza were given
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Pneumonia and secondary bacterial infections are recog-
nised to follow influenza infection in children.4 However,
studies have shown that concomitant serious bacterial
infections (SBI), especially meningitis, occur rarely in
infants during the course of infection with respiratory
viruses, including influenza and respiratory syncytial virus
(RSV).5–8 Lumbar puncture is now not specifically recom-
mended in infants presenting with RSV bronchiolitis, the
policy having evolved in recent years.9,10 Although compar-
isons have been made between the clinical characteristics of
influenza and RSV,11 there are few studies that compare
the use of invasive diagnostic procedures, especially LP, in
children with influenza with respiratory viral infections
other than RSV (ORVIs); the rates of concomitant bacterial
infection are also uncommonly reported. To this end, we
have compared the clinical characteristics, the rates of inva-
sive diagnostic procedures, particularly LP, and the inci-
dence of bacterial meningitis and bacteraemia in children
presenting with influenza or with ORVIs at the CHW, a
tertiary paediatric hospital in Greater Sydney, Australia.
Methods
Study population and setting
The study was approved by the CHW Human Research
Ethics Committee. Subjects for this study were identified
by searching the database of the department of virology at
the CHW for positive test results with influenza A, influ-
enza B, parainfluenza viruses 1, 2, 3 and adenoviruses from
nasopharyngeal aspirates and ⁄or nose ⁄ throat swabs col-
lected between 1 January and 31 December 2007. This year
was chosen as it was a peak influenza year.12 Respiratory
syncytial virus infections were excluded from the study as
it is already established that the rate of RSV and concomi-
tant bacteraemia and meningitis is very low in children.8,11
Medical records for all children thus identified were
reviewed to confirm that they had respiratory illness;
additional data on clinical presentation, investigations per-
formed and the course of illness were collected for analysis.
Baseline data on the influenza burden at our hospital for
the same year have been published elsewhere.1 Our primary
outcome measures for this study were the ‘need for’ (per-
formance of) invasive diagnostic procedures, primarily LP
but also blood culture, in children with influenza and
ORVIs and whether bacterial meningitis or bacteraemia
were concomitantly present.
Bacterial meningitis and bacteraemia were defined as the
growth of a single known bacterial pathogen in the respec-
tive specimen cultures from normally sterile sites, cerebro-
spinal fluid or blood. Urinary tract infection (UTI) was
defined as the growth of a single pathogenic organism with
108 colony-forming units ⁄ l of urine collected either by
supra-pubic aspiration, in-and-out catheter or a clean
catch. UTI was considered as coincidental infection
(bacterial infection with a definite non-pulmonary focus).
A culture was considered contaminated if there was a
growth of bacteria that are usually considered contaminants
(e.g. coagulase-negative staphylococcus) or if >1 bacterial
organism was isolated.
Laboratory methods
Children presenting to CHW with respiratory symptoms
underwent the collection of a nasopharyngeal aspirate or a
nose ⁄ throat swab according to the clinical judgement of
the treating paediatrician; it was transported to the virology
laboratory in viral transport medium at 4C. Specimens
were then batched and tested for respiratory viruses using
Simulfluor Respiratory Screen (Chemicon International,
Temecula, CA, USA). Positive samples had influenza A
confirmed with antibodies (Imagen; DakoCytomation, Ely,
UK) using direct fluorescent microscopy. Samples that were
negative for influenza A by direct immunofluorescence
were cultured on R-Mix cells (Diagnostic Hybrids, Athens,
OH, USA) at 37C for 3 days and then labelled with anti-
bodies to influenza A and influenza B (Imagen; DakoCyto-
mation) using direct fluorescent microscopy. A laboratory
diagnosis was defined by identification of a virus either by
direct fluorescent antibody (DFA) or by culture fluores-
cence.
Statistical analysis
Data analysis was carried out using the Statistical Package
for the Social Sciences (IBM SPSS Statistics 19 Inc, Somers,
NY, USA). Comparisons were made between groups on
several variables (e.g. type of respiratory viral infection,
clinical presentation and presence of any SBI) using the
chi-square test (with Yeats correction) or Fisher’s exact test
and multinominal logistic regression analysis where appro-
priate. Tests for normality were performed (Kolmogorov–
Smirnov test), and when data were normally distributed,
the differences in means between groups were compared by
the independent samples t-test. The relative risk and
corresponding 95% confidence interval (CI) were also
calculated. A P-value of £0Æ05 was considered as significant.
Results
Demography and clinical presentation
In 2007, influenza and ORVIs were laboratory-confirmed
in 294 children who are presented to the CHW. Their
median age was 14Æ5 months (range 13 days–19 years); 150
(51%) children had influenza (144 influenza A and six
influenza B) and 144 (49%) had ORVIs (89 parainfluenza
3, 44 adenovirus, six parainfluenza 1 and five parainfluenza
2). The demographics and the presenting symptoms of
these children are presented in Table 1. Of the influenza
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cases, 25 (16Æ6%) were aged <3 months compared with
nine of 144 (6Æ2%) in the ORVI group (P < 0Æ01). The dis-
tribution of respiratory viruses by age group is shown in
Figure 1. Mean body temperature on presentation was sig-
nificantly higher in the influenza group compared with that
in the ORVI group (38Æ6 versus 38Æ0C, P < 0Æ01) as was
the mean heart rate (160 versus 152, P < 0Æ01). There were
no significant differences in terms of gender, oxygen satu-
ration and respiratory rate on presentation between the
groups.
Investigations on presentation and SBI
Of the 150 influenza cases, 27 (18%) had a LP as part of
assessment compared with nine of 144 (6Æ3%) in the other
group (P < 0Æ01); 71% (107 ⁄ 150) of those with influenza
had a blood culture performed compared with 56%
(80 ⁄ 144) in the ORVI group (P < 0Æ01; Table 2).
There were no cases of bacterial meningitis in either
group. Only one child (0Æ9%) with laboratory-confirmed
influenza had bacteraemia (Enterobacter cloacae), and none
in the ORVIs had bacteraemia (P = 0Æ9). Among those
tested, 7 (10Æ6%) children with influenza had UTI diag-
nosed and another 7 (14Æ9%) children with ORVIs had
UTI (P = 0Æ57; Table 3).
Table 1. Comparison of demographics and presenting symptoms in both groups
Variables ORVIs Influenza Risk ratio (95% CI) P-value
Median age in months (range) 13 (0Æ5–18) 18 (0Æ5–19) – 0Æ13
Age £3 months, n (%) 9 (6Æ2) 25 (16Æ6) 0Æ8 (0Æ8–0Æ9) <0Æ01
Age >3–£12 months, n (%) 58 (40Æ3) 33 (22Æ0) 1Æ3 (1Æ1–1Æ5) <0Æ01
Age >12–£60 months, n (%) 63 (43Æ7) 75 (50Æ0) 0Æ8 (0Æ7–1Æ1) 0Æ29
Age >60 months, n (%) 14 (9Æ7) 17 (11Æ3) 0Æ9 (0Æ9–1Æ0) 0Æ71
Male:female 79:65 81:69 1Æ0 (0Æ7–1Æ3) 0Æ91
Mean temperature (C) 38Æ0 38Æ6 – <0Æ01
Seizure on presentation, n (%) 8 (5Æ5) 12 (8) 0Æ97 (0Æ9–1) 0Æ54
Lowest SpO2 in emergency presentation (mean) 96Æ2 96Æ3 – 0Æ59
Supplemental O2 requirements, n (%) 33 (22Æ9) 20 (13Æ3) 1Æ1 (1Æ0–1Æ2) 0Æ03
Highest HR in emergency presentation (mean) 152Æ4 159Æ7 – 0Æ02
Highest RR in presentation (mean) 39Æ5 37Æ7 – 0Æ24
SpO2, pulse oximeter oxygen saturation; HR, heart rate; ORVIs, other respiratory virus infections; RR, respiratory rate.
Figure 1. Distribution of respiratory viruses by age groups.
Table 2. Comparison of investigations, antibiotic use and hospitalisation rates in both groups
Variables ORVIs (n = 144) Influenza (n = 150) Risk ratio (95% CI) P-value
LP, n (%) 9 (6Æ2) 27 (18Æ0) 0Æ8 (0Æ8–0Æ9) <0Æ01
Blood culture, n (%) 80 (55Æ5) 107 (71Æ3) 0Æ6 (0Æ4–0Æ8) <0Æ01
Urine culture, n (%) 47 (32Æ6) 66 (44Æ0) 0Æ8 (0Æ6–0Æ9) 0Æ05
Received IV antibiotics, n (%) 65 (45Æ1) 70 (46Æ6) 0Æ9 (0Æ7–1Æ2) 0Æ81
Hospitalised, n (%) 118 (81Æ9) 122 (81Æ3) 1Æ0 (0Æ6–1Æ6) 0Æ89
ICU admission, n (%) 6 (4Æ1) 12 (8Æ0) 0Æ9 (0Æ9–1Æ0) 0Æ22
Mean LOS hospital days (SD) 4Æ9 (±8Æ4) 3Æ7 (±5Æ1) – 0Æ04
LP, lumbar puncture; IV, intravenous; ICU, intensive care unit; LOS, length of stay; ORVIs, other respiratory virus infections; SD, standard
deviation.
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Predictors of invasive procedures on presentation
In the multivariate analysis, we explored the likelihood of
an invasive procedure based on several predictors including
the presenting symptoms, age and respiratory viral diagno-
sis. A diagnosis of influenza (P = 0Æ02) and age £3 months
(P < 0Æ01) were the only significant independent predictors
of a LP, whereas a high temperature (‡39Æ5C) or having a
febrile convulsion was not predictive.
Independent predictors of having a blood culture per-
formed on presentation were as follows: a diagnosis of
influenza (P = 0Æ05) and temperature of ‡39Æ5C
(P < 0Æ01), whereas age £3 months did not reach the level
of significance (P = 0Æ06). In comparing influenza with
ORVIs, influenza-positive cases were almost three times
more likely (OR 2Æ8, 95% CI 1Æ4–5Æ9) to have had a LP
performed and 1Æ3 times (95% CI 1Æ0–1Æ5) more likely to
have a blood culture on presentation to hospital.
Most influenza cases were presented during July and
August, whereas the ORVI cases were predominant in an
overlapping period between August and October. Figure 2
shows the seasonal distribution of influenza and ORVIs
and the rate of invasive procedures according to the date
of presentation. A distinct seasonal pattern of the rate of
performance of invasive procedures corresponding to the
peak of influenza is apparent.
Discussion
Our study suggests that, whereas the risk of SBI (bacterial
meningitis or bacteraemia) was very low in children with
either influenza or ORVIs, the rate of performing invasive
procedures was significantly higher in children with influ-
enza compared with those with ORVIs. Furthermore,
whereas clinicians are more inclined to perform LP if, for
example, a child is younger, has had a febrile convulsion or
has a high fever, multivariate analysis showed that the only
two independent predictors of LP were a diagnosis of influ-
enza and age <3 months. Other studies have shown that
the risk of SBI is very low in children with respiratory viral
infection, but have not addressed whether influenza is a
strong predictor of LP being performed.6,7,13 For example,
a prospective multicentre cross-sectional study, conducted
in the USA over 3 years from 1998 to 2001, showed that
the risk of SBI in young infants was significantly lower in
children with influenza compared with those without influ-
enza.6 Another retrospective study, conducted over four
consecutive influenza seasons in the USA, demonstrated
that febrile children with influenza had a lower prevalence
of bacteraemia, UTI, consolidative pneumonia or any SBI
compared with those without influenza.7 The rate of SBI in
young infants with RSV was also lower compared with
those without RSV.8
Despite a very low prevalence of SBI, this study
demonstrates that children with influenza had significantly
higher utilisation of invasive diagnostic procedures, partic-
ularly LP. This can partly be explained by the fact that
children with influenza presented appearing more unwell as
manifested by their higher mean temperature (38Æ6 versus
38C, P < 0Æ01) and mean heart rates (160 versus 152,
P < 0Æ01). This suggests that the children with influenza
look clinically more unwell, and their presentation mimics
SBI, including meningitis, and so full septic workups,
including LP, are performed on presentation. This is
consistent with other studies conducted in our hospital in
a previous winter and one conducted elsewhere, both
Table 3. Serious bacterial infections and coincidental bacteraemia in cases of influenza or other respiratory viruses
Variable
ORVIs (n = 144) Influenza (n = 150)
n ⁄N % (95% CI) n ⁄N % (95% CI)
Bacteraemia* 0 ⁄ 80 0 1 ⁄ 107 0Æ9 (0Æ1–5)
Meningitis 0 ⁄ 9 0 0 ⁄ 27 0
UTI 7 ⁄ 47 14Æ9 (7Æ4–27Æ6) 7 ⁄ 66 10Æ6 (5–20)
N, total number of children needing the procedure; n, number of culture-positive children; ORVIs, other respiratory virus infections.
*Organism isolated: Enterobacter cloacae with influenza A.
Figure 2. Number of influenza and other respiratory viral infections
and invasive procedures according to the month of presentation.
Lumbar puncture in children with influenza
ª 2012 John Wiley & Sons Ltd 935
showing that about one-fourth of the children with influ-
enza underwent a LP.3,7
A seasonal pattern for performing blood cultures and LP
was observed in this study, the peak of which corresponded
with that of influenza infections (Figure 2). There were,
however, no cases of meningitis associated with influenza,
although admittedly the numbers in our study are not large,
and in our view, a systematic review of influenza and serious
concomitant infection is indicated to further address this
question. Our study is important in finding that the risk of
SBI in children with influenza or ORVIs was low during a
busy winter season, and yet, children with influenza undergo
significantly higher number of invasive diagnostic proce-
dures on presentation that might be reduced by improved
ascertainment of influenza directly on admission. There are
high rates of immunisation against pneumococcal, Hib and
meningococcal C disease in Western Sydney, which explains
why bacterial meningitis is now rare.14
Our study shows that about 17% of the children in the
influenza group were younger than 3 months of age, while
only 6% in the ORVI group were <3 months (P < 0Æ01).
However, overall, about half of the children in either group
were aged <1 year (Figure 1). This is consistent with find-
ings from other studies.15–17 Many of the influenza cases in
our study were too young to be immunised against influ-
enza. Considering the high burden of influenza in young
children and the frequent use of invasive diagnostic proce-
dures, it is important to consider how to rapidly screen feb-
rile children with respiratory symptoms during the
influenza season, for example, with a rapid diagnostic test.
Indeed, a rapid diagnostic test (QuickVue Influenza A + B;
Quidel Corporation, San Diego, CA, USA) performed on
nasopharyngeal aspirates evaluated at our hospital during
the 2009 pandemic season was found to be both sensitive
and specific (84% and 98Æ4%, respectively) compared with
nucleic acid testing.18 Studies conducted elsewhere also have
shown good sensitivity and specificity,19 but some rapid
diagnostic tests perform better than others and their sensi-
tivities, particularly, may vary according to the swab type,
influenza virus strain and patients’ age.20 As children with
confirmed influenza were very unlikely to suffer from men-
ingitis, rapid screening for influenza during the influenza
season may greatly reduce the need for LP; this may have
economic benefits too. A study from Spain has shown that
patients positive for influenza, using a rapid diagnostic test
in the emergency department, had a significantly reduced
rate of hospitalisation compared with those who were nega-
tive.21 A US study found that using influenza status alone,
as a screening test for infants with SBI (with a positive influ-
enza test being indicative of low risk for SBI), resulted in a
negative predictive value of 97Æ5% (95% CI 93Æ0–99Æ2%).6
From a clinical perspective, if the admitting consultant
paediatrician were to review in person all cases being
considered for LP, as occurs, for example, in Finland (T.
Heikkinen, personal communication), the proportion
undergoing the procedure may well be reduced. Notwith-
standing, if meningitis is clinically suspected, the clinician
should act accordingly, irrespective of the outcome of influ-
enza diagnostic tests.
Other respiratory virus infections were more likely to pres-
ent between 3 and 12 months of age, to require more oxygen
on admission and a longer stay in hospital: this may relate to
a greater proportion having bronchiolitis or viral pneumoni-
tis than the influenza cases did. Most of the influenza cases
(89Æ3%) in our study presented during July and August, the
southern hemisphere winter influenza season. Clinicians
should consider a diagnosis of influenza in febrile unwell
children presenting during peak months of influenza activity.
There are some limitations in our study. Firstly, DFA
and virus culture were employed for diagnosing respiratory
viruses as that was the practice in 2007 at our hospital.
Owing to lower sensitivity of these tests compared with
nucleic acid tests,22 some respiratory viral infections may
have been missed; however, that being the case, it may help
to better explain the apparent close association between the
peaks of influenza diagnosis and performance of LP. Direct
fluorescent antibody and other rapid antigen tests may pro-
vide more rapid turnaround times than nucleic acid testing,
thus allowing LP to be avoided. Another limitation is that
other respiratory viruses like rhinovirus, coronavirus,
enterovirus, human metapneumovirus (hMPV) and human
bocavirus were not looked for.
A systematic review addressing the risk of concomitant
influenza and bacterial meningitis should be performed.
Rapid screening of febrile infants with respiratory symp-
toms during periods of known influenza activity may help
to avert the use of LP, particularly if these cases are clini-
cally reviewed by the senior admitting consultant, who, if
still suspicious of concomitant bacterial meningitis, can
ensure the LP is performed.
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